Atrioventricular block during fetal life

[1]  R. Wakai,et al.  In Utero Diagnosis of Long QT Syndrome by Magnetocardiography , 2013, Circulation.

[2]  U. Elkayam,et al.  Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials. , 2013, Autoimmunity reviews.

[3]  J. Morris,et al.  To B or not to B cells‐mediate a healthy start to life , 2013, Clinical and experimental immunology.

[4]  B. Cuneo,et al.  Fetal Heart Rate Predictors of Long QT Syndrome , 2012, Circulation.

[5]  John M. Simpson,et al.  Isolated Atrioventricular Block in the Fetus: A Retrospective, Multinational, Multicenter Study of 175 Patients , 2011, Circulation.

[6]  Mimi Y. Kim,et al.  Maternal and Fetal Factors Associated With Mortality and Morbidity in a Multi–Racial/Ethnic Registry of Anti-SSA/Ro–Associated Cardiac Neonatal Lupus , 2011, Circulation.

[7]  B. Tutschek,et al.  Pulsed‐wave tissue Doppler echocardiography for the analysis of fetal cardiac arrhythmias , 2011, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[8]  J. Kingdom,et al.  Prolongation of the atrioventricular conduction in fetuses exposed to maternal anti-Ro/SSA and anti-La/SSB antibodies did not predict progressive heart block. A prospective observational study on the effects of maternal antibodies on 165 fetuses. , 2011, Journal of the American College of Cardiology.

[9]  M. Wahren-Herlenius,et al.  Diagnostic precision of Doppler flow echocardiography in fetuses at risk for atrioventricular block , 2010, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[10]  J. Kingdom,et al.  The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants. , 2010, Journal of the American College of Cardiology.

[11]  Mimi Y. Kim,et al.  Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine , 2010, Annals of the rheumatic diseases.

[12]  A Tincani,et al.  Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study. , 2010, Arthritis and rheumatism.

[13]  Mimi Y Kim,et al.  Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial. , 2010, Arthritis and rheumatism.

[14]  Mimi Y. Kim,et al.  Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors. , 2009, Arthritis and rheumatism.

[15]  A. Brucato,et al.  The impact of treatment of the fetus by maternal therapy on the fetal and postnatal outcomes for fetuses diagnosed with isolated complete atrioventricular block , 2009, Cardiology in the Young.

[16]  D. Mevorach,et al.  Early Diagnosis and Treatment of Atrioventricular Block in the Fetus Exposed to Maternal Anti-SSA/Ro-SSB/La Antibodies: A Prospective, Observational, Fetal Kinetocardiogram–Based Study , 2009, Circulation.

[17]  Michael W. Jackson,et al.  Ro 60 functions as a receptor for beta(2)-glycoprotein I on apoptotic cells. , 2009, Arthritis and rheumatism.

[18]  R. Clancy.  When the levee doesn't break: a novel role of beta2-glycoprotein I to protect against congenital heart block. , 2009, Arthritis and rheumatism.

[19]  A. Baschat,et al.  Regression of fetal heart block and myocardial echogenicity with steroid therapy in maternal Sjögren's syndrome , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[20]  V. Aiello,et al.  Perinatal Outcome of Fetal Atrioventricular Block: One-Hundred-Sixteen Cases From a Single Institution , 2008, Circulation.

[21]  R. Wakai,et al.  Magnetocardiography for fetal arrhythmias. , 2008, Heart rhythm.

[22]  K. Bremme,et al.  Outcome and Growth of Infants Fetally Exposed to Heart Block-Associated Maternal Anti-Ro52/SSA Autoantibodies , 2008, Pediatrics.

[23]  Mimi Y. Kim,et al.  Utility of Cardiac Monitoring in Fetuses at Risk for Congenital Heart Block: The PR Interval and Dexamethasone Evaluation (PRIDE) Prospective Study , 2008, Circulation.

[24]  S. Takeda,et al.  Effect of steroid administration and plasmapheresis to prevent fetal congenital heart block in patients with systemic lupus erythematosus and/or Sjögren's syndrome , 2007, Acta obstetricia et gynecologica Scandinavica.

[25]  A. Parthiban,et al.  Progressive fetal atrioventricular block in heterotaxy syndrome , 2007, Cardiology in the Young.

[26]  Salome Oseku-Afful,et al.  PR interval: a comparison of electrical and mechanical methods in the fetus. , 2007, Early human development.

[27]  E. Kulinskaya,et al.  Fetal ECG: a novel predictor of atrioventricular block in anti-Ro positive pregnancies , 2006, Heart.

[28]  M. Wahren-Herlenius,et al.  Doppler echocardiographic and electrocardiographic atrioventricular time intervals in newborn infants: evaluation of techniques for surveillance of fetuses at risk for congenital heart block , 2006, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[29]  J. Kingdom,et al.  Assessment of fetal atrioventricular time intervals by tissue Doppler and pulse Doppler echocardiography: normal values and correlation with fetal electrocardiography , 2006, Heart.

[30]  I. Konstantinov,et al.  Doppler tissue imaging in the assessment of atrioventricular conduction time: validation of a novel technique and comparison with electrophysiologic and pulsed wave Doppler-derived equivalents in an animal model. , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[31]  A. Tincani,et al.  Normal neuropsychological development in children with congenital complete heart block who may or may not be exposed to high-dose dexamethasone in utero , 2006, Annals of the rheumatic diseases.

[32]  J. Simpson,et al.  Outcome after preterm delivery of infants antenatally diagnosed with congenital heart disease. , 2006, The Journal of pediatrics.

[33]  P. Lorenz,et al.  Identification and management of fetuses at risk for, or affected by, congenital heart block associated with autoantibodies to SSA (Ro), SSB (La), or an HsEg5-like autoantigen , 2006, Rheumatology International.

[34]  S. Luo,et al.  Successful preventive treatment of congenital heart block during pregnancy in a woman with systemic lupus erythematosus and anti-Sjögren's syndrome A/Ro antibody. , 2005, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[35]  A. Baschat,et al.  Atrioventricular block detected in fetal life: associated anomalies and potential prognostic markers , 2005, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[36]  E. Rosenthal,et al.  Letter regarding article by Jaeggi et al, "transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease". , 2005, Circulation.

[37]  J. Stange,et al.  Autoimmune‐associated Congenital Heart Block: Treatment of the Mother With Immunoadsorption , 2005, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[38]  J. Smallhorn,et al.  Transplacental Fetal Treatment Improves the Outcome of Prenatally Diagnosed Complete Atrioventricular Block Without Structural Heart Disease , 2004, Circulation.

[39]  P. Stoutenbeek,et al.  Treatment of fetal heart block with maternal steroid therapy: case report and review of the literature , 2004, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[40]  J. Kingdom,et al.  Is immune‐mediated complete fetal atrioventricular block reversible by transplacental dexamethasone therapy? , 2004, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[41]  K. Bremme,et al.  Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies. , 2004, Arthritis and rheumatism.

[42]  Mimi Y. Kim,et al.  The Fetal Doppler Mechanical PR Interval: A Validation Study , 2003, Fetal Diagnosis and Therapy.

[43]  E. Rosenthal,et al.  Successful management of fetal hydrops due to congenitally complete atrioventricular block , 2003, Cardiology in the Young.

[44]  N. Silverman,et al.  Maternal Anti-Ro and Anti-La Antibody–Associated Endocardial Fibroelastosis , 2002, Circulation.

[45]  Robert M Hamilton,et al.  Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution's experience of 30 years. , 2002, Journal of the American College of Cardiology.

[46]  G. Andelfinger,et al.  Reference values for time intervals between atrial and ventricular contractions of the fetal heart measured by two Doppler techniques. , 2001, The American journal of cardiology.

[47]  L. Gilstrap.  Antenatal Corticosteroids Revisited: Repeat Courses—National Institutes of Health Consensus Development Conference Statement, August 17–18, 2000 , 2001, Obstetrics and gynecology.

[48]  K. Leveno,et al.  Antenatal Dexamethasone and Decreased Birth Weight , 2001, Obstetrics and gynecology.

[49]  H. Julkunen,et al.  The rate of recurrence of isolated congenital heart block: a population-based study. , 2001, Arthritis and rheumatism.

[50]  T. Tikanoja,et al.  Short- and Long-Term Outcome of Children With Congenital Complete Heart Block Diagnosed In Utero or as a Newborn , 2000, Pediatrics.

[51]  D. Friedman,et al.  Pulsed Doppler echocardiographic assessment of the fetal PR interval. , 2000, The American journal of cardiology.

[52]  A Kandori,et al.  Magnetocardiographic determination of the developmental changes in PQ, QRS and QT intervals in the foetus , 2000, Acta paediatrica.

[53]  D. Friedman,et al.  Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. , 1999, Arthritis and rheumatism.

[54]  I. Furuta,et al.  Fetal Treatment of Congenital Heart Block Ascribed to Anti‐SSA Antibody: Case Reports with Observation of Cardiohemodynamics and Review of the Literature , 1999, American journal of reproductive immunology.

[55]  D. Friedman,et al.  Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. , 1998, Journal of the American College of Cardiology.

[56]  E. Rosenthal,et al.  Therapeutic trial of sympathomimetics in three cases of complete heart block in the fetus. , 1995, Circulation.

[57]  J. Buyon,et al.  Successful in utero therapy of fetal heart block. , 1995, American journal of obstetrics and gynecology.

[58]  J. Copel,et al.  In Utero identification and therapy of congenital heart block , 1995, Lupus.

[59]  N. Silverman,et al.  Perinatal outcome of fetal complete atrioventricular block: a multicenter experience. , 1991, Journal of the American College of Cardiology.

[60]  S. Campbell,et al.  Evaluation of fetal arrhythmias by echocardiography. , 1983, British heart journal.

[61]  A. Becker,et al.  The Conducting Tissues in Congenitally Corrected Transposition , 1974, Circulation.

[62]  Stephen G. Miller,et al.  Maternal autoantibody levels in congenital heart block and potential prophylaxis with antiinflammatory agents. , 2013, American journal of obstetrics and gynecology.

[63]  J. Buyon,et al.  Neonatal lupus: advances in understanding pathogenesis and identifying treatments of cardiac disease. , 2012, Current opinion in rheumatology.

[64]  E. Tarım,et al.  Sjögren's syndrome diagnosed in pregnancy: a case report. , 2005, The Journal of reproductive medicine.

[65]  J. Buyon,et al.  Intravenous immunoglobulin and placental transport of anti-Ro/La antibodies: comment on the letter by Kaaja and Julkunen. , 2004, Arthritis and rheumatism.

[66]  R. Kaaja,et al.  Prevention of recurrence of congenital heart block with intravenous immunoglobulin and corticosteroid therapy: comment on the editorial by Buyon et al. , 2003, Arthritis and rheumatism.

[67]  A. Baschat,et al.  P330: Heart block detected in fetal life—associated anomalies and possible prognostic markers , 2003 .

[68]  R. Friedman,et al.  Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. , 2001, Journal of the American College of Cardiology.

[69]  L. Shenker.  Fetal arrhythmias. , 1987, Journal of the American College of Cardiology.

[70]  M. A. Engle,et al.  Congenital complete heart block: an international study of the natural history. , 1972, Cardiovascular clinics.